Quent Capital’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Other funds holding SRPT
Quent Capital's SRPT Position: Q3 2026 in Review
Quent Capital reduced its Sarepta Therapeutics (SRPT) stake by 83% in Q3 2026, selling an estimated $6.19K and leaving 69 shares worth $1.25K. The position accounts for ﹤0.01% of the portfolio, ranked #1562.
Quent Capital first reported a position in SRPT in Q4 2022 and has held it in 15 quarters since. The position peaked at $16K in Q1 2026. 305 funds tracked by Wall St. Rank hold SRPT as of Q3 2026.
- Quent Capital held 69 shares of Sarepta Therapeutics worth $1.25K as of Q3 2026.
- Quent Capital sold 331 Sarepta Therapeutics shares in Q3 2026, an estimated $6.19K.
- Sarepta Therapeutics made up ﹤0.01% of Quent Capital's portfolio in Q3 2026, its #1562 holding.
- Quent Capital first reported a position in Sarepta Therapeutics in Q4 2022 and has held it in 15 quarters since.
- Quent Capital's Sarepta Therapeutics position peaked at $16K in Q1 2026.
- 305 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2026.
Based on Quent Capital's 13F filing for Q3 2026, filed 9 Nov 2026.